Oxaliplatin in Unresectable Hepatocellular Carcinoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary:
- To determine the Tumor Response Rate of patients with hepatocellular carcinoma treated
with the combination chemotherapy of Eloxatin+5-Fluorouracil/Leucovorin
Secondary:
- Safety and tolerability of this regimen in these patients